{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T20:02:19Z","timestamp":1770753739887,"version":"3.50.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,5,10]]},"DOI":"10.7759\/cureus.38842","type":"journal-article","created":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T17:24:17Z","timestamp":1683739457000},"source":"Crossref","is-referenced-by-count":2,"title":["When Breathing Becomes a Challenge: A Case of Congenital Myasthenia Gravis in an Indian Neonate With a DOK-7 Gene Mutation"],"prefix":"10.7759","author":[{"given":"Vaidehi","family":"Mendpara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjay","family":"Bethanabotla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megha","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vaishnavi","family":"Kanisetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gurpreet","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhirami","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sweta","family":"Sahu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitesh","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10112235","article-title":"Myasthenia gravis: epidemiology, pathophysiology and clinical manifestations","volume":"10","author":"Dresser L","year":"2021","unstructured":"Dresser L, Wlodarski R, Rezania K, Soliven B. Myasthenia gravis: epidemiology, pathophysiology and clinical manifestations. J Clin Med. 2021, 10:10.3390\/jcm10112235","journal-title":"J Clin Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.20592","article-title":"Transient neonatal myasthenia gravis: a case report","volume":"13","author":"Santiago Gon\u00e7alves C","year":"2021","unstructured":"Santiago Gon\u00e7alves C, Nunes Marques MI, Antunes S, Serrano A. Transient neonatal myasthenia gravis: a case report. Cureus. 2021, 13:e20592. 10.7759\/cureus.20592","journal-title":"Cureus"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1590\/0004-282X20160134","article-title":"Congenital myasthenic syndromes and myasthenia gravis are challenging diagnoses in neurological practice","volume":"74","author":"Nucci A","year":"2016","unstructured":"Nucci A. Congenital myasthenic syndromes and myasthenia gravis are challenging diagnoses in neurological practice. Arq Neuropsiquiatr. 2016, 74:695-6. 10.1590\/0004-282X20160134","journal-title":"Arq Neuropsiquiatr"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-019-1025-5","article-title":"Congenital myasthenic syndromes","volume":"14","author":"Finsterer J","year":"2019","unstructured":"Finsterer J. Congenital myasthenic syndromes. Orphanet J Rare Dis. 2019, 14:57. 10.1186\/s13023-019-1025-5","journal-title":"Orphanet J Rare Dis"},{"key":"ref5","article-title":"Congenital myasthenic syndromes overview","author":"Abicht A","year":"2003","unstructured":"Abicht A, M\u00fcller JS, Lochm\u00fcller H. Congenital myasthenic syndromes overview. GeneReviews\u00ae[Internet]. Adam MP, Mirzaa GM, Pagon RA, Wallace SE, Bean LH, Gripp KW, Amemiya A (ed): University of Washington, Seattle; 2003."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2021.07.400","article-title":"Congenital myasthenic syndromes: where do we go from here?","volume":"31","author":"Ramdas S","year":"2021","unstructured":"Ramdas S, Beeson D. Congenital myasthenic syndromes: where do we go from here?. Neuromuscul Disord. 2021, 31:943-54. 10.1016\/j.nmd.2021.07.400","journal-title":"Neuromuscul Disord"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(14)70201-7","article-title":"Congenital myasthenic syndromes: pathogenesis, diagnosis, and treatment","volume":"14","author":"Engel AG","year":"2015","unstructured":"Engel AG, Shen XM, Selcen D, Sine SM. Congenital myasthenic syndromes: pathogenesis, diagnosis, and treatment. Lancet Neurol. 2015, 14:420-34. 10.1016\/S1474-4422(14)70201-7","journal-title":"Lancet Neurol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-009-5405-y","article-title":"Phenotype genotype analysis in 15 patients presenting a congenital myasthenic syndrome due to mutations in DOK7","volume":"257","author":"Ben Ammar A","year":"2010","unstructured":"Ben Ammar A, Petit F, Alexandri N, et al.. Phenotype genotype analysis in 15 patients presenting a congenital myasthenic syndrome due to mutations in DOK7. J Neurol. 2010, 257:754-66. 10.1007\/s00415-009-5405-y","journal-title":"J Neurol"},{"key":"ref9","article-title":"Congenital myasthenia gravis (a case report)","volume":"31","author":"Joshi RM","year":"1985","unstructured":"Joshi RM, Bharucha BA, Mohire MD, Kumta NB. Congenital myasthenia gravis (a case report). J Postgrad Med. 1985, 31:109-11.","journal-title":"J Postgrad Med"},{"key":"ref10","article-title":"A case report of congenital myasthenia gravis presenting with respiratory distress","volume":"4","author":"Shervin Badv R","year":"2018","unstructured":"Shervin Badv R, Memarian S, Ghahvechi M, et al.. A case report of congenital myasthenia gravis presenting with respiratory distress. Casp J Neurol Sci. 2018, 4:35-8.","journal-title":"Casp J Neurol Sci"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-011-0234-7","article-title":"Congenital myasthenic syndromes in 2012","volume":"12","author":"Engel AG","year":"2012","unstructured":"Engel AG. Congenital myasthenic syndromes in 2012. Curr Neurol Neurosci Rep. 2012, 12:92-101. 10.1007\/s11910-011-0234-7","journal-title":"Curr Neurol Neurosci Rep"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1230273100","article-title":"Myasthenic syndrome caused by mutation of the SCN4A sodium channel","volume":"100","author":"Tsujino A","year":"2003","unstructured":"Tsujino A, Maertens C, Ohno K, et al.. Myasthenic syndrome caused by mutation of the SCN4A sodium channel. Proc Natl Acad Sci U S A. 2003, 100:7377-82. 10.1073\/pnas.1230273100","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/CND.0000000000000222","article-title":"Congenital myasthenic syndrome: spectrum of mutations in an Indian cohort","volume":"20","author":"Selvam P","year":"2018","unstructured":"Selvam P, Arunachal G, Danda S, et al.. Congenital myasthenic syndrome: spectrum of mutations in an Indian cohort. J Clin Neuromuscul Dis. 2018, 20:14-27. 10.1097\/CND.0000000000000222","journal-title":"J Clin Neuromuscul Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/mus.20944","article-title":"Variable phenotypes associated with mutations in DOK7","volume":"37","author":"Anderson JA","year":"2008","unstructured":"Anderson JA, Ng JJ, Bowe C, McDonald C, Richman DP, Wollmann RL, Maselli RA. Variable phenotypes associated with mutations in DOK7. Muscle Nerve. 2008, 37:448-56. 10.1002\/mus.20944","journal-title":"Muscle Nerve"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03672-3","article-title":"Mechanism of disease and therapeutic rescue of Dok7 congenital myasthenia","volume":"595","author":"Oury J","year":"2021","unstructured":"Oury J, Zhang W, Leloup N, et al.. Mechanism of disease and therapeutic rescue of Dok7 congenital myasthenia. Nature. 2021, 595:404-8. 10.1038\/s41586-021-03672-3","journal-title":"Nature"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awm068","article-title":"Phenotypical spectrum of DOK7 mutations in congenital myasthenic syndromes","volume":"130","author":"M\u00fcller JS","year":"2007","unstructured":"M\u00fcller JS, Herczegfalvi A, Vilchez JJ, et al.. Phenotypical spectrum of DOK7 mutations in congenital myasthenic syndromes. Brain. 2007, 130:1497-506. 10.1093\/brain\/awm068","journal-title":"Brain"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/S0035-3787(13)70060-2","article-title":"[Congenital myasthenic syndromes: difficulties in the diagnosis, course and prognosis, and therapy--The French National Congenital Myasthenic Syndrome Network experience]","volume":"169","author":"Eymard B","year":"2013","unstructured":"Eymard B, Stojkovic T, Sternberg D, et al.. [Congenital myasthenic syndromes: difficulties in the diagnosis, course and prognosis, and therapy--The French National Congenital Myasthenic Syndrome Network experience]. Rev Neurol (Paris). 2013, 169:45-55. 10.1016\/S0035-3787(13)70060-2","journal-title":"Rev Neurol (Paris)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2012.11.004","article-title":"Salbutamol benefits children with congenital myasthenic syndrome due to DOK7 mutations","volume":"23","author":"Burke G","year":"2013","unstructured":"Burke G, Hiscock A, Klein A, et al.. Salbutamol benefits children with congenital myasthenic syndrome due to DOK7 mutations. Neuromuscul Disord. 2013, 23:170-5. 10.1016\/j.nmd.2012.11.004","journal-title":"Neuromuscul Disord"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181dd43bf","article-title":"Ephedrine treatment in congenital myasthenic syndrome due to mutations in DOK7","volume":"74","author":"Lashley D","year":"2010","unstructured":"Lashley D, Palace J, Jayawant S, Robb S, Beeson D. Ephedrine treatment in congenital myasthenic syndrome due to mutations in DOK7. Neurology. 2010, 74:1517-23. 10.1212\/WNL.0b013e3181dd43bf","journal-title":"Neurology"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2015.09.019","article-title":"Effective treatment with albuterol in DOK7 congenital myasthenic syndrome in children","volume":"54","author":"Tsao CY","year":"2016","unstructured":"Tsao CY. Effective treatment with albuterol in DOK7 congenital myasthenic syndrome in children. Pediatr Neurol. 2016, 54:85-7. 10.1016\/j.pediatrneurol.2015.09.019","journal-title":"Pediatr Neurol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awm072","article-title":"Clinical features of the DOK7 neuromuscular junction synaptopathy","volume":"130","author":"Palace J","year":"2007","unstructured":"Palace J, Lashley D, Newsom-Davis J, et al.. Clinical features of the DOK7 neuromuscular junction synaptopathy. Brain. 2007, 130:1507-15. 10.1093\/brain\/awm072","journal-title":"Brain"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2013.06.002","article-title":"DOK7 congenital myasthenic syndrome in childhood: early diagnostic clues in 23 children","volume":"23","author":"Klein A","year":"2013","unstructured":"Klein A, Pitt MC, McHugh JC, et al.. DOK7 congenital myasthenic syndrome in childhood: early diagnostic clues in 23 children. Neuromuscul Disord. 2013, 23:883-91. 10.1016\/j.nmd.2013.06.002","journal-title":"Neuromuscul Disord"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2021.e06869","article-title":"A novel DOK7 mutation causing congenital myasthenic syndrome with limb-girdle weakness: case series of three family members","volume":"7","author":"Alsallum MS","year":"2021","unstructured":"Alsallum MS, Alshareef A, Abuzinadah AR, Bamaga AK, Dallol A. A novel DOK7 mutation causing congenital myasthenic syndrome with limb-girdle weakness: case series of three family members. Heliyon. 2021, 7:e06869. 10.1016\/j.heliyon.2021.e06869","journal-title":"Heliyon"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21408","article-title":"Dok-7 myasthenia: phenotypic and molecular genetic studies in 16 patients","volume":"64","author":"Selcen D","year":"2008","unstructured":"Selcen D, Milone M, Shen XM, Harper CM, Stans AA, Wieben ED, Engel AG. Dok-7 myasthenia: phenotypic and molecular genetic studies in 16 patients. Ann Neurol. 2008, 64:71-87. 10.1002\/ana.21408","journal-title":"Ann Neurol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/152443-when-breathing-becomes-a-challenge-a-case-of-congenital-myasthenia-gravis-in-an-indian-neonate-with-a-dok-7-gene-mutation","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:59:26Z","timestamp":1707508766000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/152443-when-breathing-becomes-a-challenge-a-case-of-congenital-myasthenia-gravis-in-an-indian-neonate-with-a-dok-7-gene-mutation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,10]]},"references-count":24,"URL":"https:\/\/doi.org\/10.7759\/cureus.38842","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5,10]]}}}